The Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse awarded a $119,605 firm fixed price purchase order to Coherent NA, Inc. for a Coherent Monaco 1035-40-40 LX series I high-power stimulation laser for cellular manipulation. The laser must deliver at least 40 microjoules per pulse to meet the technical requirements specified in Solicitation Number NIH-NIDA-RFP-23-001 for this research equipment. Coherent Inc. is the parent company of Coherent NA. The period of performance is September 1, 2023 through August 31, 2029 at the prime contractor's place of performance in Plymouth, Michigan. This award will support the National Institute on Drug Abuse's ongoing research efforts to better understand addiction and related health issues.
Generated 12/23/23, 4:20 PM